Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	79,157,526	78,463,162	67,544,125	54,092,240	58,433,854	59,746,994
Market Cap Growth	18.44%	16.17%	24.87%	-7.43%	-2.20%	9.32%
Enterprise Value	78,620,526	77,724,732	67,525,830	54,470,491	57,778,382	59,669,231
Last Close Price	1710000.00	1695000.00	1203851.91	964096.37	1041477.78	1133459.52
PE Ratio	49.04	43.98	62.35	63.07	73.22	151.80
Forward PE	45.63	42.21	62.18	60.08	82.37	112.20
PS Ratio	17.37	17.22	14.85	14.64	19.47	38.10
PB Ratio	10.62	10.53	6.19	5.50	6.50	11.97
P/TBV Ratio	10.62	10.53	8.52	8.23	10.14	12.05
P/FCF Ratio	-	-	189.90	80.60	-	1235.91
P/OCF Ratio	-	-	40.71	32.46	61.31	131.43
PEG Ratio	1.47	1.46	3.24	3.45	3.32	3.45
EV/Sales Ratio	17.25	17.06	14.85	14.74	19.25	38.05
EV/EBITDA Ratio	-	-	35.19	33.97	44.72	85.35
EV/EBIT Ratio	37.98	37.55	51.15	48.91	58.74	111.05
EV/FCF Ratio	-	-	189.85	81.16	-	1234.30
Debt / Equity Ratio	0.12	0.12	0.14	0.19	0.28	0.26
Debt / EBITDA Ratio	-	-	0.77	1.19	1.95	1.85
Debt / FCF Ratio	-	-	4.18	2.85	-	26.74
Net Debt / Equity Ratio	-0.07	-0.07	0.01	-0.01	-0.08	-0.02
Net Debt / EBITDA Ratio	-	-	0.08	-0.09	-0.53	-0.11
Net Debt / FCF Ratio	-	-	0.44	-0.22	179.20	-1.63
Asset Turnover	0.32	0.32	0.27	0.23	0.24	0.22
Inventory Turnover	-	-	0.83	0.76	0.91	1.02
Quick Ratio	0.57	0.57	0.35	0.50	0.76	1.24
Current Ratio	1.74	1.74	1.43	1.33	1.54	2.55
Return on Equity (ROE)	-	-	10.45%	9.12%	11.42%	8.21%
Return on Assets (ROA)	-	-	4.94%	4.27%	5.01%	4.67%
Return on Invested Capital (ROIC)	17.18%	17.54%	10.06%	9.48%	11.77%	7.98%
Return on Capital Employed (ROCE)	24.30%	24.30%	9.80%	9.40%	7.90%	7.80%
Earnings Yield	2.25%	2.27%	1.60%	1.59%	1.37%	0.66%
FCF Yield	-	-	0.53%	1.24%	-0.01%	0.08%
Buyback Yield / Dilution	-	-	-	-1.95%	-5.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.